Correlation Between Caribou Biosciences and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Conduit Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and Conduit Pharmaceuticals
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Caribou and Conduit is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Conduit Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.24 times less risky than Conduit Pharmaceuticals. The stock trades about -0.23 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 10.00 in Conduit Pharmaceuticals on September 12, 2024 and sell it today you would lose (0.60) from holding Conduit Pharmaceuticals or give up 6.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Caribou Biosciences |
| Conduit Pharmaceuticals |
Caribou Biosciences and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Conduit Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
| Conduit Pharmaceuticals vs. Equillium | Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Valneva SE ADR | Conduit Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |